rna dna and cancer
RNA/DNA and Cancer
$321.00 Original price was: $321.00.$4.99Current price is: $4.99. Add to cart
Sale!

RNA/DNA and Cancer

Original price was: $321.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Nucleic Acid Assault: RNA/DNA and Cancer

Cancer is, at its absolute core, a disease of corrupted information. The DNA is mutated, and the RNA translates those mutations into the physical proteins that destroy the body. RNA/DNA and Cancer is a fiercely advanced, highly technical molecular pathology manual detailing the exact mechanics of this genetic corruption. This volume provides the precise biochemical blueprints required to read, understand, and intercept the fundamental code driving every malignancy.

Mastering MicroRNA (miRNA) Dysregulation

The core philosophy of this text is the control of expression. The authors aggressively detail the mechanics of post-transcriptional silencing. It dictates exactly how tiny, non-coding pieces of RNA (miRNAs) normally act as the brakes on cellular growth, and exactly how a tumor genetically deletes these specific miRNAs, allowing massive, unchecked production of oncogenic proteins (like MYC or RAS) to flood the cell.

Navigating Epigenetic Methylation

The book provides a masterclass in silencing the tumor suppressors. It dictates the exact molecular pathways of DNA modification. It rigorously explores how a cancer cell can physically attach methyl groups to the promoter region of a healthy, life-saving gene (like p53), literally turning the gene “off” without actually changing its DNA sequence, proving that cancer is as much a disease of epigenetics as it is genetics.

Frequently Asked Questions (FAQs)

Does this book provide surgical techniques for removing tumors?
No, it is a highly advanced *molecular genetics, bioinformatics, and cellular biology textbook* focused entirely on the fundamental genetic and epigenetic mechanisms of the disease.

Who is the primary audience?
It is the absolute, mandatory benchtop reference for Cancer Geneticists, Molecular Biologists, Bioinformaticians, and Translational Researchers.